Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates from a Korean hospital that carry blaOXA-23

Infection, Genetics and Evolution

Volumn 58, Issue , 2018, Pages 232-236

  Jeon, Hyejin ^a   Kim, Shukho ^a   Kim, Mi Hyun ^a   Kim, Se Yeon ^a   Nam, Donghyuk ^a   Park, Sung Chan ^a   Park, Sue Hyun ^a   Bae, Hanna ^a   Lee, Hyeon Jeong ^a   Cho, Jae Hyun ^a   Lee, Won Kil ^a   Lee, Yoo Chul ^a   Lee, Sang Hwa ^b   Shin, Min Sang ^a   Lee, Je Chul ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Dong A University   (South Korea)

Author keywords

Carbapenem; Clone; Epidemicity; Resistance; Sequence type

Indexed keywords

AMIKACIN; BETA LACTAMASE; BETA LACTAMASE OXA 23; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DORIPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA-LACTAMASE OXA-23, ACINETOBACTER BAUMANNII; CARBAPENEM DERIVATIVE;

AACA4 GENE; AACC1 GENE; AADA1 GENE; ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; APHA1 GENE; APHA6 GENE; ARMA GENE; ARTICLE; BACTERIUM ISOLATE; BLAPER 1 GENE; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE; HEALTH CARE FACILITY; MOLECULAR CLONING; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; ACINETOBACTER INFECTION; BETA-LACTAM RESISTANCE; BIOFILM; DRUG EFFECT; GENETICS; GENOTYPE; HUMAN; PHENOTYPE; VIROLOGY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BIOFILMS; CARBAPENEMS; GENOTYPE; HUMANS; MULTILOCUS SEQUENCE TYPING; PHENOTYPE;

EID: 85044476566     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2018.01.003     Document Type: Article

References (41)

1. Al Atrouni, A., Hamze, M., Jisr, T., Lemarié, C., Eveillard, M., Joly-Guillou, M.L., Kempf, M., Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon. Int. J. Infect. Dis. 52 (2016), 29–36.
2. Aly, M.M., Abu Alsoud, N.M., Elrobh, M.S., Al Johani, S.M., Balkhy, H.H., High prevalence of the PER-1 gene among carbapenem-resistant Acinetobacter baumannii in Riyadh, Saudi Arabia. Eur. J. Clin. Microbiol. Infect. Dis. 35 (2016), 1759–1766.
3. PER-1 genes among multidrug resistant Acinetobacter baumannii in a teaching hospital in Iran. J. Pathog., 2015, 2015, 957259.
4. Bartual, S.G., Seifert, H., Hippler, C., Luzon, M.A., Wisplinghoff, H., Rodríguez-Valera, F., Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43 (2005), 4382–4390.
5. Bonnin, R.A., Naas, T., Poirel, L., Nordmann, P., Phenotypic, biochemical, and molecular techniques for detection of metallo-β-lactamase NDM in Acinetobacter baumannii. J. Clin. Microbiol. 50 (2012), 1419–1421.
6. Cho, Y.J., Moon, D.C., Jin, J.S., Choi, C.H., Lee, Y.C., Lee, J.C., Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals. Diagn. Microbiol. Infect. Dis. 64 (2009), 185–190.
7. Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing: twenty-fifth informational supplement. Document M100-S25, 2015, CLSI, Wayne, PA, USA.
8. Dijkshoorn, L., Nemec, A., Seifert, H., An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5 (2007), 939–951.
9. Espinal, P., Marti, S., Vila, J., Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J. Hosp. Infect. 80 (2012), 56–60.
10. Falagas, M.E., Kasiakou, S.K., Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 40 (2005), 1333–1341.
11. Gaddy, J.A., Actis, L.A., Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol 4 (2009), 273–278.
12. Gayoso, C.M., Mateos, J., Méndez, J.A., Fernández-Puente, P., Rumbo, C., Tomás, M., Martínez de Ilarduya, O., Bou, G., Molecular mechanisms involved in the response to desiccation stress and persistence in Acinetobacter baumannii. J. Proteome Res. 13 (2014), 460–476.
13. Gurung, M., Rho, J.S., Lee, Y.C., Kim, H.S., Moon, S.Y., Yu, B.H., Lee, J.H., Jang, C.W., Chung, S.Y., Cho, I.H., Jee, H.S., Choi, S.W., Heo, J.Y., Lee, J.C., Emergency and spread of carbapenem resistant Acinetobacter baumannii sequence type 191 in a Korean hospital. Infect. Genet. Evol. 19 (2013), 219–222.
14. Henwood, C.J., Gatward, T., Warner, M., James, D., Stockdale, M.W., Spence, R.P., Towner, K.J., Livermore, D.M., Woodford, N., Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936). J. Antimicrob. Chemother. 49 (2002), 479–487.
15. Héritier, C., Poirel, L., Lambert, T., Nordmann, P., Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 49 (2005), 3198–3202.
16. Hu, Y., He, L., Tao, X., Meng, F., Zhang, J., Biofilm may not be necessary for the epidemic spread of Acinetobacter baumannii. Sci. Rep., 6, 2016, 32066.
17. Jeon, B.C., Jeong, S.H., Bae, I.K., Kwon, S.B., Lee, K., Young, D., Lee, J.H., Song, J.S., Lee, S.H., Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea. J. Clin. Microbiol. 43 (2005), 2241–2245.
18. Kim, D.H., Jung, S.I., Kwon, K.T., Ko, K.S., Occurrence of diverse AbGRI1-type genomic islands in Acinetobacter baumannii global clone 2 isolates from South Korea. Antimicrob. Agents Chemother. 61 (2017), e01972–16.
19. Lee, H.W., Koh, Y.M., Kim, J., Lee, J.C., Lee, Y.C., Seol, S.Y., Cho, D.T., Kim, J., Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin. Microbiol. Infect. 14 (2008), 49–54.
20. Lee, Y., Bae, I.K., Kim, J., Jeong, S.H., Lee, K., Dissemination of ceftazidime-resistant Acinetobacter baumannii clonal complex 92 in Korea. J. Appl. Microbiol. 112 (2012), 1207–1211.
21. Lin, Y.C., Hsia, K.C., Chen, Y.C., Sheng, W.H., Chang, S.C., Liao, M.H., Li, S.Y., Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan. Antimicrob. Agents Chemother. 54 (2010), 2078–2084.
22. Longo, F., Vuotto, C., Donelli, G., Biofilm formation in Acinetobacter baumannii. New Microbiol. 37 (2014), 119–127.
23. Magiorakos, A.P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., Harbarth, S., Hindler, J.F., Kahlmeter, G., Olsson-Liljequist, B., Paterson, D.L., Rice, L.B., Stelling, J., Struelens, M.J., Vatopoulos, A., Weber, J.T., Monnet, D.L., Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18 (2012), 268–281.
24. OXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 16 (2010), 35–40.
25. Neely, A.N., A survey of gram-negative bacteria survival on hospital fabrics and plastics. J. Burn Care Rehabil. 21 (2000), 523–527.
26. Oikonomou, O., Sarrou, S., Papagiannitsis, C.C., Georgiadou, S., Mantzarlis, K., Zakynthinos, E., Dalekos, G.N., Petinaki, E., Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in central Greece: mechanisms of resistance, molecular identification and epidemiological data. BMC Infect. Dis., 15, 2015, 559.
27. Peleg, A.Y., Seifert, H., Paterson, D.L., Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21 (2008), 538–582.
28. Perez, L.R., Acinetobacter baumannii displays inverse relationship between meropenem resistance and biofilm production. J. Chemother. 27 (2015), 13–16.
29. Perez, F., Hujer, A.M., Hujer, K.M., Decker, B.K., Rather, P.N., Bonomo, R.A., Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51 (2007), 3471–3484.
30. Pfizer Inc. (Wyeth Pharmaceuticals Inc.), Tygacil® Product Insert. 2014, Pfizer Inc., Philadelphia, PA http://www.pfizerpro.com/hcp/tygacil.
31. Poirel, L., Nordmann, P., Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12 (2006), 826–836.
32. PER-1 gene in gram-negative bacteria. Antimicrob. Agents Chemother. 49 (2005), 1708–1713.
33. Pournaras, S., Dafopoulou, K., Del Franco, M., Zarkotou, O., Dimitroulia, E., Protonotariou, E., Poulou, A., Zarrilli, R., Tsakris, A., Greek Study Group on Acinetobacter Antimicrobial Resistance, Predominance of international clone 2 OXA-23-producing-Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide study. Int. J. Antimicrob. Agents 49 (2017), 749–753.
34. Qi, C., Malczynski, M., Parker, M., Scheetz, M.H., Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J. Clin. Microbiol. 46 (2008), 1106–1109.
35. Rodríguez-Baño, J., Martí, S., Soto, S., Fernández-Cuenca, F., Cisneros, J.M., Pachón, J., Pascual, A., Martínez-Martínez, L., McQueary, C., Actis, L.A., Vila, J., Spanish Group for the Study of Nosocomial Infections (GEIH), Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin. Microbiol. Infect. 14 (2008), 276–278.
36. Ruan, Z., Chen, Y., Jiang, Y., Zhou, H., Zhou, Z., Fu, Y., Wang, H., Yu, Y., Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. Int. J. Antimicrob. Agents 42 (2013), 322–328.
37. Selasi, G.N., Nicholas, A., Jeon, H., Lee, Y.C., Yoo, J.R., Heo, S.T., Lee, J.C., Genetic basis of antimicrobial resistance and clonal dynamics of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital. Infect. Genet. Evol. 36 (2015), 1–7.
38. Selasi, G.N., Nicholas, A., Jeon, H., Na, S.H., Kwon, H.I., Kim, Y.J., Heo, S.T., Oh, M.H., Lee, J.C., Differences in biofilm mass, expression of biofilm-associated genes, and resistance to desiccation between epidemic and sporadic clones of carbapenem-resistant Acinetobacter baumannii sequence type 191. PLoS One, 11, 2016, e0162576.
39. Visca, P., Seifert, H., Towner, K.J., Acinetobacter infection-an emerging threat to human health. IUBMB Life 63 (2011), 1048–1054.
40. Wong, D., Nielsen, T.B., Bonomo, R.A., Pantapalangkoor, P., Luna, B., Spellberg, B., Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin. Microbiol. Rev. 30 (2017), 409–447.
41. Zowawi, H.M., Sartor, A.L., Sidjabat, H.E., Balkhy, H.H., Walsh, T.R., Al Johani, S.M., Al Jindan, R.Y., Al Faresi, M., Ibrahim, E., Al-Jardani, A., Al Salman, J., Dashti, A.A., Johani, K., Paterson, D.L., Molecular epidemiology of carbapenem resistant Acinetobacter baumannii in the Gulf Cooperation Council States. Dominance of OXA-23-typeproducers. J. Clin. Microbiol. 53 (2015), 896–903.